ASXL1 and acute myeloid leukemia: The mutational frequency of ASXL1 in Puerto Rican Hispanic AML patients was significantly lower than that in the Darbinyan cohort [2], and the mutational frequencies of WT1 and KRAS were significantly lower than that in the Bradley cohort [6].